Search results for "Weight loss"
Guideline suggests prescription medications when lifestyle change ineffective for weight loss
For adults with obesity or overweight with weight-related complications, the American Gastroenterological Association found moderate certainty of benefit for four medications: semaglutide, liraglutide, phentermine-topiramate ER, or naltrexone-bupropion.
https://gastroenterology.acponline.org/archives/2022/10/28/6.htm
28 Oct 2022
RYGB associated with more alcohol-related hospitalizations than other weight-loss strategies
A recent cohort study compared hospitalizations related to alcohol use disorder and mortality among veterans who received Roux-en-Y gastric bypass (RYGB) surgery, sleeve gastrectomy, or referral to a weight management program.
https://gastroenterology.acponline.org/archives/2022/12/23/3.htm
23 Dec 2022
Phentermine-topiramate most effective drug for weight loss, meta-analysis finds
Among glucagon-like peptide-1 receptor agonists, semaglutide appeared to be the most effective for weight loss, with a higher likelihood of weight loss of 5% or more and percentage body weight change and a similar risk of adverse events.
https://gastroenterology.acponline.org/archives/2021/12/17/7.htm
17 Dec 2021
Food insecurity associated with less weight loss, even with intense intervention
The findings of a recent randomized trial suggest that weight loss approaches need to address both obesity and food insecurity, both of which continue to increase in the U.S.
https://gastroenterology.acponline.org/archives/2021/03/26/6.htm
26 Mar 2021
Recent-onset diabetes, weight loss associated with increased pancreatic cancer risk
Unintentional weight loss and weight loss in those with a body mass index already in the normal range were particularly associated with risk of pancreatic cancer among patients with recent-onset diabetes, a study found.
https://gastroenterology.acponline.org/archives/2020/09/25/6.htm
25 Sep 2020
Postapproval studies find risks of gastric balloon devices used for weight loss
A small number of patients experienced balloon hyperinflation and acute pancreatitis with the Orbera and ReShape liquid-filled intragastric balloons.
https://gastroenterology.acponline.org/archives/2020/05/22/8.htm
22 May 2020
FDA requests withdrawal of weight-loss drug from U.S. market
The manufacturer of lorcaserin will voluntarily withdraw the drug because a safety clinical trial showed that the drug was associated with an increased occurrence of cancer compared to placebo.
https://gastroenterology.acponline.org/archives/2020/02/28/6.htm
28 Feb 2020
Weight loss through gastric bypass or diet improved insulin sensitivity in patients with type 2 diabetes
Results from this small study suggest that reducing adipose tissue volume, by whatever means, will improve blood glucose control in patients with type 2 diabetes, an accompanying editorial noted.
https://gastroenterology.acponline.org/archives/2020/09/25/7.htm
25 Sep 2020
MKSAP Quiz: 4-month history of diarrhea
A 21-year-old man is evaluated for a 4-month history of diarrhea. Bowel movements are liquid and nonbloody and sometimes are preceded by lower abdominal cramps. He has near-daily bloating. Following a physical exam and lab tests, what is the most appropriate management?
https://gastroenterology.acponline.org/archives/2024/09/27/4.htm
27 Sep 2024
Diagnostic delays in pancreatic cancer relatively common, likely avoidable, study suggests
Thirty-eight percent of patients with pancreatic cancer experienced a diagnostic delay of at least 60 days, with lack of recognition of objective weight loss as the most common cause, a Veterans Affairs study showed.
https://gastroenterology.acponline.org/archives/2024/08/23/1.htm
23 Aug 2024